1 / 1
Pharmazeutisch
Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
